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Polymorphonuclear (PMN) leukocytes mediate that 
phase of inflammation at which vascular responses be-
come translated into tissue injury. After phagocytosis, 
the PMN leukocyte generates derivatives of molecular 
oxygen (02 - ., OH·, and H 20 2) that stimulate a metabolic 
burst and assist in the killing of microorganisms. They 
also release oxidation products of membrane fatty acids 
(e.g., arachidonate), which are detected as thromboxanes 
and prostaglandins. After interaction of phagocytic li-
gands (immune complexes and C3b-opsonized particles), 
the PMN leukocyte secretes lysosomal enzymes from 
open phagocytic vacuoles, and, especially when phago-
cytosis is blocked by cytochalasin B, secretes them di-
rectly into the cell's surrounding fluids. Secretion is 
enhanced by agents that elevate intracellular levels of 
cyclic GMP, and inhibited by agents that raise cyclic 
AMP. These reciprocal changes are associated with as-
sembly and disassembly (respectively) of cytoplasmic 
microtubules. These cytoskeletal structures, together 
with contractile elements, regulate in part the secretory 
events of inflammation in which lysosomal constituents 
(e.g., elastase, collagenase, and cathepsin G) are diverted 
from their intracellular depots to an inappropriate as-
sault on the tissues of the host. 
A common histological feature of most acute, immunologi-
cally induced tissue injury is the accumulation of polymorpho-
nuclear (PMN) leukocytes at the site of reaction. Recently, we 
have come to appreciate that these cells are not merely innocent 
bystanders to the events that occur at a focus of inflammation; 
rather, they play an active role in the mediation of these events. 
Metchnikoff [1] and, later, Menkin [2] proposed that leuko-
cytes may liberate substances capable of damaging adjacent 
tissues. It was not until a number of years later, however, that 
a crucial role for PMN leukocytes in the production of certain 
experimental, immunologically induced inflammatory reactions 
was demonstrated. The vasculitis of the Arthus reaction was 
the first experimentally produced lesion found to be dependent 
on these cells. Specific removal of PMN leukocytes by treat-
ment with nitrogen mustard or heterologous antineutrophil 
sera inhibit this reaction in several species [3-7]. Microscopi-
cally, no evidence of vascular injury can be detected in depleted 
animals, even though deposits of antigen, antibody; and com-
plement can easily be demonstrated. Similarly, t he necrotizing 
arteritis of experimental serum sickness in rabbits [8], the 
proteinuria associated with acute nephrotoxic nephritis in rats 
and rabbits [9], and the arthritis in rabbits produced by an 
intra-articular reversed passive Arthus reaction [10] can all be 
prevented by depletion of PMN leukocytes in these animals. In 
the last system, it is possible to reconstitute the synovial lesion 
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in neutrophil-depleted rabbits by intra-articular injections of 
purified suspensions of PMN leukocytes. 
Central to t his role are the inflammatory substances con-
tained within these cells, particularly those sequestered within 
their cytoplasmic granules, or lysosomes. These not only pro-
duce cartilage destruction by themselves, but can interact with 
components of the complement [11] and kinin [12] systems or 
are directly inflammatory (cationic proteins). 
THE PHAGOCYTIC FUNCTION OF THE 
GRANULOCYTE 
When a matme PMN leukocyte encounters a suitable, inges-
tible particle, the surface membmne of the celJ invaginates and 
surrounds it. The vesicle containing the particle, now called a 
phagosome or phagocytic vesicle, pinches off from the surface 
and is introduced into the cytoplasm of the cell [13-15]. The 
extent of particle uptake may be limited by the availability of 
surface membrane. Cells that have not been exposed to particles 
have irregular shapes and appear to possess redundant surface 
area in the form of pseudopods and blebs. After phagocytosis, 
the cells are rounded and have far less available plasma mem-
brane. Digestion of the engulfed paJ,ticle is initiated by the 
fusion of the membranes of the granules with the phagosome 
membrane. The lysosomes subsequently discharge their con-
tents into the phagosome, a process called degranulation 
[16,17], and the vesicle is now a "phagolysosome. " Degranula-
tion of specific lysosomes seems to occm before that of azurophil 
granules [18]. These processes have been illustrated in recent 
experiments in which we have employed the freeze-fracture 
technique to study membrane fusion during phagocytosis 
(Fig 1). 
THE TWO GRANULE SUBPOPULATIONS 
Specific granules of PMN leukocytes contain lysozyme 
[19,20], that hydrolyzes cell wall peptidoglycan of some bacte-
rial species, alkaline phosphatase (rabbit and guinea pig gran-
ulocytes), collagenase [21], vitamin BIz-binding protein [22], 
and lactoferrin [23], an iron-binding protein with bacteriostatic 
properties. Azurophil granules, which may consist of two re-
solvable populations [20], also contain lysozyme [19,20]. Unlike 
the specific granules, azurophils appeaJ- to contain all of the 
cellular myeloperoxidase, low-molecular-weigh t bactericidal 
cationic proteins [23] (which can directly increase vascular 
permeability or can cause histamine release), acid hydrolases 
(beta-glucw·onidase, acid phosphatase, alpha-mannosidase, N-
acetyl-beta-glucosaminidase) , and neutral proteases (the last 
two categories apperu· to have digestive as well as bactericidal 
functions) [15,20,24]. 
With respect to the tissue destruction observed in inflam-
matory reactions, the most important granule contents are the 
proteases. In PMN leukocytes, there are fom well-defined ly-
sosomal proteases (which we have reviewed in detail elsewhere 
[25]): elastase, collagenase, cathepsin G, and cathepsin D. These 
four are not the only active proteases in PMN leukocytes, but 
they probably account for the bulk of the lysosomal attack on 
extracellulru· structures. 
These proteases are quite capable of degrading two major 
components of extracellular matrix: collagen and proteoglycan. 
The former component is hydrolyzed by collagenase, the latter 
by cathepsin D, and bot h components ru·e attacked by elastase 
and cathepsin G. The neutral proteases may also contribute to 
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F IG 1. F reeze-fractu red replicas of human peripheral blood neutro-
phils (PMN leukocyte) (reduced from X 43,000). A, A port ion of a 
cross-fractm ed, rest ing PM N leukocyte. Note the typical P MN gran-
ules. T he fracture plane has exposed part of the plasma membrane P 
face (PM-P) and the P faces of some granules (P) and E faces of others 
(E). B , A por t ion of a P MN leukocyte with ingested zymosan. T he 
fracture plane exposes part of the plasma membrane P face (PM -P) 
and the E faces of several vacuoles (V) . T hese cells were fixed 4 min 
after exposure to zymosan; phagocytosis is st ill not complete . What 
appears to be the opening of a phagocyt ic vacuole can be seen in the 
plasma membrane (arrow). C, T he in terior of a P M N leukocyte 4 min 
after exposure to zymosan. Both E and P faces of phagocytic vacuoles 
are exposed. The particle distribu tion in the plasma membrane P faces 
seen in A and B are more nearly s imilar to the vacuolar E face than to 
the vacuolar P face that is derived from it . 
inflammatory reactions by generating chemotactic factors fro m 
C5 [26] and releasing kinin-like materials fro m plasma kinino-
gens [27). Of the fo ur enzymes, elastase is probably the one 
most responsible for t issue damage, both because of its broad 
substrate specificity and because of its abundance in human 
P MN leukocytes. 
POLYMORPHONUCLEAR LEUKOCYTE RESPONSE 
TO SURF ACE STIMULAT ION AND P ARTICLES 
The response of P MN leukocytes to foreign materials pro-
ceeds through several partially resolvable stages at various 
biochemical and immunologic levels. In general, a ll of the 
responses are geared toward phagocytic ingestion and the even-
tual destruction of invading microbes. 
P hagocytosis by P MN leukocytes is strongly influenced by 
certain characteristics of the target particles. In particular , 
ingestion is dependent on surface proper ties of the part icle; 
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variations in hydrophobicity and sUlface change can profoundly 
influence ingestion rates. No "rules" for optimum surface prop-
erties are yet apparent [28). 
The job of the granulocyte is facilitated by the system of 
humoral immunity in the host; particles that have been exposed 
to fresh serum are engulfed far more readily than untreated 
particles (opsonization) . One opsonic component of serum is 
the IgG class antibody (in particular, the IgG 1 and IgG~ sub-
classes). Both the Fab portion of the antibody molecule, which 
binds specific sites on the particle, and the Fc moiety, which 
presumably interacts with the PMN leukocyte membrane, must 
be intact [29]. Because IgG molecules al'e resistant to heating, 
opsonic activity mediated by immunoglobulins is termed "heat-
stable." 
Serum complement also has opsonic power that is character-
istically heat-labile. The most active factor, C3b, is generated 
by proteolytic cleavage of the C3 complement component; this 
cleavage results from activation of either the classical hemolytic 
pathway or the properdin system. The C3b may also be formed 
by the direct action of proteases such as plasmin or trypsin. 
T he C3b pept ides at tach to target particles by firm bonds and 
are subsequently removed by a proteolytic enzyme (C3b inac-
t ivator) found in normal serum [30). The fact that opsonization 
displays stringent requirements for C3b peptides or Fc portions 
of IgG1 or IgG3 molecules suggests that these moieties interact 
with specific neutrophil membrane receptors. As yet, no such 
C3b or Fc receptors have been isolated, but other proper ties of 
opsonization are consistent with their existence. 
MET ABOLIC RESPONSES 
When PMN leukocytes encounter ingestible par ticles, 
prompt metabolic changes are observed. These responses in-
clude increased oxygen consumption [31,32], increased hexose 
monophosphate shunt activity [33], increased hydrogen perox-
ide [34] and superoxide anion [35] production, and increased 
lipid turnover [36). A critical first step in these events is the 
reduction of molecular oxygen to superoxide anion (02- ') by an 
oxidase (or oxidases) linked either to NADH or NADPH. T he 
exact nature of th e oxidase, its reduced pyridine nucleotide 
specificity, and its subcellular location are currently in dispute. 
Superoxide anion is enzymatically (by superoxide dismutase) 
or spontaneously conver ted to hydrogen peroxide, which may 
in turn react with addit ional O2- , to form hydroxyl radical 
(OH ·). All of these species of oxygen are highly reactive and 
possess various degrees of bactericidal activity. Hydrogen per-
oxide is particularly important in that it is responsible for 
stimulation of hexose monophosphate shunt activity; the re-
quired oxidation of NADP H by HZ0 2 is mediated by glutathi-
one-linked reactions [37). Consumpt ion of hydrogen peroxide 
by this mechanism and by cytoplasmic catalase provides PMN 
leukocytes with the means to protect themselves against this 
noxious compound. 
There is evidence that some, if not all, of the reactive oxygen 
moieties of the neutrophil are originally generated by enzymes 
on the plasma membrane. In particular, a number of agents 
that eit her perturb or act directly on the cell surface can trigger 
the metabolic events discussed above [38- 41). This idea i 
appealing since generation of superoxide and other reactive 
derivatives at the plasma membrane level would be advanta-
geous; toxic bactericidal materials would thus be concentrated 
around ingested organisms (and minimized in the cell cytoplasm 
and extracellular space) once the membrane was formed into 
phagosomes. Although the advantages of such a system are 
great and the evidence for it has been growing, the data are 
nonetheless indirect and the subcellular localization of the 
critical oxidase has not been achieved. 
CYTOSKELET AL ELE MENTS 
Microtubules and microfilaments, the most prominent cyto-
skeletal structures of PMN leukocytes, appear to be intimately 
involved in the processes of cell motili ty, adhesion, and inges-
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tion [42,43]. These structw'es generate motive power for the 
leukocytes and could conceivably mediate a transfer of infor-
mation between plasma membrane and the cell interior. 
Microtubule assembly can be controlled in a variety of ways 
both in vivo and in vitro. The presence of calcium ions promotes 
dissolution of polymerized tubulin and thus provides yet an-
other role for this versatile cation. Agents that elevate intracel-
lular levels of cyclic GMP (cGMP), such as phorbol myristate 
acetate and carbamylcholine, favor assembly of tubulin; mate-
rials such as prostaglandin EI (PGEd and isoproterenol, which 
elevate cyclic AMP (cAMP) levels, promote disassembly. Re-
cent results suggest that the redox state of the cell might also 
regulate the polymerization of tubulin [44]. Further manipula-
tion of micro tubules can be achieved in vitro. The dimer:poly-
mer equilibrium can be "frozen" by molar concentrations of 
sucrose or glycerol. Assembly can be promoted by the presence 
of D 20. Finally, and of great practical importance, reversible 
dissolution of micro tubules can be accomplished with micro-
molar concentrations of the alkaloids colchicine and vinblastine. 
In PMN leukocytes, microtubules seem to be of particular 
importance. The number of these structures increases when 
cells are exposed to various surface stimuli [45], including the 
chemotactic factor C5a [46]. The fact that colchicine can inhibit 
particle ingestion (in some phagocytic systems), chemotaxis, 
migration, sW'face adhesion, and degranulation suggests that 
microtubules are important in all of these processes. Microtu-
buies have been implicated in other more subtle phenomena. 
There is evidence that these structures can govern the planar 
disposition of membrane components during phagocytosis; mi-
crotubules appear to be able to prohibit [47] or promote ' [48] 
the incorporation of various membrane markers into phago-
somes. 
Microfilaments are smaller than microtubules, 6 nm in di-
ameter, and seem to constitute the contractile system of PMN 
leukocytes. These structures have been identified as actin pol-
ymers and are prominent in areas of the cell involved in 
adh esion and particle ingestion [43]. Strong similarities between 
the contractile system of PMN leukocytes and that of skeletal 
muscle have recently become apparent. Actin, myosin (with 
actin-activated Mg++-ATPase activity), actin-binding protein, 
and a cofactor that allows actin to activate the above-mentioned 
ATPas~ have all been isolated from phagocytic cells [49]. 
Appropriate extracts of rabbit alveolar macrophages can be 
induced to form gels and to contract in vitro; significantly more 
actin-binding protein can be obtained from phagocytizing than 
from resting cells [50]. 
The microfIlament system can be inhibited by interference 
with production of metabolic energy (A TP). More specific 
disruption of the contractile system can be achieved with cy-
tochalasin B. The cytochalasins are fungal metabolites that, in 
low concentrations, interfere with the fu nction of actin-binding 
protein [51]. Although the effect of cytochalasin B is usually 
assumed to be specific against microfilaments, this drug is also 
known to inhibit hexose transport [52]; interpretations of ex-
perimental results should be tempered with this knowledge. 
The fact that cytochalasin B is a powerful inhibitor of migration 
and phagocytosis in PMN leukocytes, in conjunction with ul-
trastructural data, suggests a vital role for microfIlaments in 
these active processes [42,53,54]' 
DEGRANULATION 
Under normal conditions, degranulation is a di.rect accom-
paniment of phagocytosis, and the close relationship between 
these events suggests common, or at least similar, triggering 
mechanisms [53]. During degranulation, lysosomes fuse with 
phagosomes containing ingested particles and thus dischru'ge 
their contents in concentrated form in the immediate vicinity 
of their target. Ideally, both the extracellular milieu and the 
cytoplasm of PMN leukocytes are spru'ed the deleterious effects 
of the granule enzymes. In practice, some lysosomal contents 
are released outside the cell during particle ingestion, usually 
because of premature degranulation into those phagosomes 
that are still open at the cell surface ("regurgitation during 
feeding"). 
Extensive extracellular degranulation can be stimulated in 
some pathologic or experimental systems. For example, a PMN 
leukocyte might try to ingest an oversized particle such as 
opson.in-coated swface; phagocytosis cannot be accomplished, 
but degranulation would be stimulated and would result in 
extracellular dischru'ge of lysosomal contents (a process called 
"reverse endocytosis"). Exposure to immune complexes dis-
persed on millipore filters, that cannot be phagocytized effec-
tively, similarly induces extracellular degranulation [55]. An 
experimental system for the study ofthese processes is provided 
by neutrophils whose ability to ingest particles is blocked by 
the presence of cytochalasin B. The surfaces of such cells can 
be stimulated by a variety of agents such as particles, opsonins, 
or lectins, and stimulation leads to extrusion of the granule (but 
not of the cytoplasmic) contents. Ultrastructural and biochem-
ical studies on cytochalasin B-treated cells have revealed mem-
brane fusion between lysosomal granules and the plasma mem-
brane as the morphological accompaniment of biochemically 
measurable enzyme release [56]. Here, cytochalasin B converts 
PMN leukocytes from phagocytic cells into model secretory 
cells; consequently, it is possible to monitor extra.cellula.rly 
(after fusion of lysosomes with plasma membranes) processes 
that ordinarily occur intra.cellula.rly (fusion of lysosomes with 
phagocytic vacuoles). The fact that degranulation by cytochal-
asin B-treated cells in inhibited by colchicine and increased by 
phorbol myristate acetate suggests an active role for microtu-
buies in this process. Degranulation is also inhibited by corti-
costeroids, which interfere generally with fusion of membranes 
[57] and in particular with fusion of granules and plasma 
membranes. 
RELEASE OF PROSTAGLANDINS AND 
THROMBOXANES 
P hagocytizing PMN leukocytes release prostaglandins and 
thromboxanes, which are potent mediators of inflammation. 
Their exact roles in inflammation ru'e unclear; data ' in the 
literature ru'e complex and often conflicting. In the past, studies 
on these compounds were usually conducted with aggregating 
platelets, which produce them in abundance; only more recently 
have PMN leukocytes been used. 
We have seen that the metabolic burst that accompanies 
phagocytosis produces a variety of reactive oxygen species: 
superoxide anion, hydroxyl radical, singlet oxygen, and hydro-
gen peroxide. One or more of these materials (the material 
varies from system to system), or simply molecular oxygen, 
reacts with a C20 polyunsaturated fatty acid, either arachidonic 
acid or eicosatrienoic acid, mediated by the enzyme cyclooxy-
genase. This enzyme, which is also called prostaglandin synthe-
tase, is inhibited by the anti-inflammatory drugs indomethacin 
and aspirin. The fatty acid endoperoxides thus formed, called 
the prostaglandin G (PGG) and prostaglandin H (PGH) series, 
have their own biological activities [58], but more importantly, 
t hey serve as in termediates in the formation of other prosta-
glandins and thl'omboxanes. The PGH can be converted by 
isomerases to PGE2, PGEI, and PGF2n ; PGEz is an important 
mediator of inflammation. Both PGH2 and PGG2 can be con-
verted into thromboxane A2. Synthesis of prostaglandins and 
thromboxanes appears to be substrate-limited; production is 
significantly increased when free long-chain fatty acid is sup-
plied. Thus, enzymes such as fatty acid synthetases or phos-
pholipases that could control availabili ty of substrate may 
regulate prostaglandin and thromboxane synthesis. Thrombox-
ane A2 is unstable and is rapidly converted to the inactive form, 
thromboxane B2. In vivo, the prostaglandins ru'e quickly de-
graded enzymatically. Consequently, these compounds are 
short-lived and are most effective near sites of production 
[54]. 
Although the reported effects of prostaglandins and throm-
boxanes are often contradictory, a reasonable generalization is 
that prostaglandins in nanogram quantities promote inflam-
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mation, particularly edema and erythema [59]. T hromboxane 
B2 and PGE 1 have both been labeled chemotactic for PMN 
leukocytes. A hydroxyl derivative of arachidonic acid, HETE, 
is produced in platelets by a separate lipooxygenase reaction 
and a lso appears to be chemotactic for PMN leukocytes [60]. 
Thromboxane A2 agglutinates platelets and is a powerful vas-
oconstrictor [61]. On the other hand, PGE 1 seems to inhibit 
certain aspects of inflammation by raisin g intracellular levels of 
cAMP; this would decrease extracellular degranulation by neu-
trophils [62]. 
EXTRUSION OF POLYMORPHONUCLEAR 
LEUKOCYTE GRANULE ENZYMES IN TISSUE 
INJURY 
Recent work on PMN leukocytes has led to the appreciation 
that cell surface recognition of, and stimulation by, th ree dis-
tinct ligands can provoke granule translocation, membrane 
fusion, and selective extracellular release of granule contents. 
These ligands include Fc regions of IgG molecules that have 
undergone a conformational change either because they have 
combined with antigen or because of heat aggregation (Fc 
receptor stimulus), fragme nts of the th ird component of com-
plement (C3b receptor stimulus), and t he soluble, low molecular 
weight complement component, C5a. For example, immune 
complexes prepared by the reaction of heat-aggregated human 
IgG with rheumatoid factor or heat-aggregated IgG alone, either 
in suspension or deposited on nonphagocytizable surfaces, are 
capable of provoking the selective discharge of lysosomal con-
stituents from human PMN leukocytes (by "regurgitation dur-
ing feeding" or "reverse endocytosis") [46,56,62-65]. The PMN 
leukocytes exposed to fragments of C3 fIxed on nonphagocytiz-
able surfaces respond in a similar manner (in the presence of 
IgG) . The C5a, generated by activation of either the classical or 
the alternative complement pathways, is capable, in the absence 
of particles (or immunoglobulins), of interacting with human' 
PMN leukocytes to stimulate membrane fusion between lyo-
somal granules and between these organelles and th e plasma 
membrane [46]. In cytochalasin B-treated PMN leukocytes [46] 
and in PMN leukocytes adh ering to nonphagocytizable surfaces 
[65], this fusion leads to selective extracellular release of lyso-
somal enzymes by the process of "reverse endocytosis." 
T he exocytosis, or degranulation, that follows cell surface 
stimulation by immune reactants appears to involve both major 
classes of PMN leukocyte granules, azurophils and specifIcs. 
Consequently, acid hydro lases such as beta-glucuronidase (from 
azurophils) and lysozym e (from specific granules) can be de-
tected in t he medium surrounding such stimulated cells [46, 
56,62- 65]. In contrast, some nonimmune stimuli appear to 
provoke selective discharge (by exocytosis) of only specillc 
granule constituents (e.g., lysozyme) from human PMN leuko-
cytes. These stimuli include the tumor promoter, phorbol my-
ristate acetate [66], concanavalin A [45], and ionized calcium 
[67], either in the presence or a bsence of the divalent cation 
ionophore A23187. These observations, together with reported 
sequential degranulation during phagocytosis [18], indicate that 
slightly different m echanisms are responsible for discharge of 
t he two types of granules. 
PHARMACOLOGIC CONTROL OF ENZYME RELEASE 
Because lysosomal enzyme release may be crucial to the 
pathogenesis of tissue injury and inflammation, it is likely that 
reductions in enzyme release would prove benefIcial. Therefore, 
considerable attention has been directed to the effect on these 
mechanisms of enzyme release by agents that regulate the 
secretion of stored proteins in tissues such as pancreas, salivary 
gland, and th yroid. Two major types of compounds have been 
studied; those that affect the state or function of cytoplasmic 
microtubules directly, and those that influence the intracellular 
level of cAMP and cGMP . As would be expected, these com-
pounds have no effect upon mechanisms involving cell death or 
"perforation from within" (crystal-induced enzyme release). 
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T hey do, however, influence enzyme release by the mechanisms 
of "regurgitation dUl'ing feeding" and "reverse endocytosis." 
Exogenous cAMP (plus theophylline) and agents that elevate 
cellular levels of cAMP (e.g., PGE 1 and isoproterenol) reduce 
enzyme release from PMN leukocytes, whereas exogenous 
cGMP and agents that elevate levels of cGMP (e.g., serotonin 
and carbamylcholine) enhance it [62]. Similarly, agents that 
promote disassembly of cytoplasmic microtubules (e.g., colchi-
cine and vinblastine) reduce lysosomal enzyme release, whereas 
agents th at promote microtubule assembly (e.g., deuterium 
oxide) enhance it. Although it had been tempting to suggest 
that a relationship existed between cyclic nucleotides, micro-
tubules, and enzyme release from PMN leukocytes, recent work 
has shown that microtubule assembly is only necessary for 
maximum secretion, and that secretion is not invariably asso-
ciated with tubule assembly ' [53]. 
Some of the a nt i-inflammatory effects of cor t icosteroids can 
be attributed to inhibition of PMN leukocyte locomotion, phag-
ocytosis, and degranulation. An interesting speculation is that 
these drugs stabilize membranes and thus inhibit the fusion 
between membrane surfaces [57] on which both phagocytosis 
and degranulation depend. This may prove to be the most 
important anti-inflammatory mechanism produced by cortico-
steroids. T he nonsteroid anti-inflammatory drugs aspirin and 
indomethacin do not affect granule release. However, t hese 
drugs do reduce PMN leukocyte-mediated tissue injury by 
inhibiting the cyclooxygenase responsible for prostaglandin and 
thromboxane production. 
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